Furthermore, literature data on CGH array and copy number alterations highlight a high frequency of gain at 8q24 region where the c-MYC oncogene maps [19, 28–30], which could explain the higher number of copies of long c-MYC fragments in urine samples from prostate cancer patients than in those from healthy individuals. Here, MYC is linked to prostate carcinoma.